共 32 条
[1]
Bromberg JE(2013)Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation–an International Primary Central Nervous System Lymphoma Study Group project Haematologica 98 808-813
[2]
Ghose A(2015)Influence of rituximab on central nervous system relapse in diffuse large B-cell lymphoma and role of prophylaxis–A systematic review of prospective studies Clin Lymphoma Myeloma Leuk 15 451-457
[3]
El-Galaly TC(2018)Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma Eur J Cancer 93 57-68
[4]
Tang K(2021)Real-world experiences of CAR T-cell therapy for large B-cell lymphoma: How similar are they to the prospective studies? J Immunother Precis Oncol 4 150-159
[5]
Nastoupil LJ(2017)Anti-CD19 CAR T cells in CNS diffuse large-B-cell lymphoma N Engl J Med 377 783-784
[6]
Abramson JS(2022)Chemokine-driven migration of pro-inflammatory CD4(+) T cells in CNS autoimmune disease Front Immunol 13 817473-6179
[7]
Heng AHS(2011)Cutting edge: loss of alpha4 integrin expression differentially affects the homing of Th1 and Th17 cells J Immunol 187 6176-1711
[8]
Glatigny S(2006)CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells J Exp Med 203 1701-571
[9]
Liu W(2018)Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Nat Med 24 563-5630
[10]
Fraietta JA(2021)CAR T-cell therapy for secondary CNS DLBCL Blood Adv 5 5626-977